Patent 7305442
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-pro
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings Overview
There have been zero AIA trial proceedings filed against US patent 7,305,442. This provides a defendant with a clean slate, as no claims have been previously challenged or validated at the PTAB, and no estoppel applies from prior art that could have been raised in such a proceeding.
Strategic Summary
The complete absence of PTAB challenges against US patent 7,305,442 means all claims—both independent (1, 7, 9) and dependent (2-6, 8)—remain untested in post-grant proceedings. For a defendant, this is a double-edged sword. On one hand, the patent is not "hardened" by surviving an IPR, and the full universe of prior art patents and printed publications is available for a potential validity challenge. On the other hand, there is no existing record of the Patent Owner's arguments or the Board's analysis on claim construction or validity, which can sometimes provide a roadmap for a defense.
From an estoppel perspective, a defendant is in a strong position. Because no IPRs have been filed, the estoppel provisions of 35 U.S.C. § 315(e)(2) do not apply. A defendant is free to petition for IPR on any grounds based on prior art patents or printed publications that it can identify, without concern that those grounds were or could have been raised in a prior proceeding. The lack of PTAB activity is itself a notable data point; patents that are frequently asserted often attract defensive IPR petitions from defendants or third-party groups like Unified Patents. The silence here could suggest a lack of aggressive assertion by the patent owner.
Recommended Next Steps
For a defendant facing an assertion of US patent 7,305,442, the key takeaway is that no inter partes review (IPR), post-grant review (PGR), or covered business method (CBM) review has ever been filed.
This means:
- All validity challenge options are on the table. A defendant can conduct a prior art search and, if strong art is found, file an IPR petition at the PTAB without any procedural bars from previous trials.
- The patent's strength is unknown. Without a prior challenge, it is difficult to gauge how the Patent Trial and Appeal Board might construe the claims or view the patent's validity over the prior art.
- No pre-existing record. A defendant and its counsel would need to develop their invalidity contentions from scratch, without the benefit of seeing how the patent owner has previously defended the patent's claims at the PTAB.
Given this situation, the immediate and most critical next step for any defendant is to commission a thorough prior art search focused on the asserted claims. The outcome of that search will dictate the viability of filing a new IPR petition and will be the foundation of any invalidity defense in district court.
Generated 5/12/2026, 9:43:17 PM